rs61741003
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_005157.6(ABL1):c.128G>A(p.Ser43Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000388 in 1,614,142 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_005157.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ABL1 | NM_005157.6 | c.128G>A | p.Ser43Asn | missense_variant | 2/11 | ENST00000318560.6 | |
ABL1 | NM_007313.3 | c.185G>A | p.Ser62Asn | missense_variant | 2/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ABL1 | ENST00000318560.6 | c.128G>A | p.Ser43Asn | missense_variant | 2/11 | 1 | NM_005157.6 | ||
ABL1 | ENST00000372348.9 | c.185G>A | p.Ser62Asn | missense_variant | 2/11 | 1 | P1 | ||
ABL1 | ENST00000393293.4 | c.182G>A | p.Ser61Asn | missense_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00167 AC: 254AN: 152142Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000481 AC: 121AN: 251426Hom.: 0 AF XY: 0.000390 AC XY: 53AN XY: 135876
GnomAD4 exome AF: 0.000254 AC: 372AN: 1461882Hom.: 1 Cov.: 30 AF XY: 0.000248 AC XY: 180AN XY: 727246
GnomAD4 genome AF: 0.00167 AC: 255AN: 152260Hom.: 1 Cov.: 32 AF XY: 0.00159 AC XY: 118AN XY: 74430
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
ABL1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 06, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at